168 related articles for article (PubMed ID: 18480610)
1. Pure eye muscle involvement in endocrine orbitopathy.
Gerlach M; Ferbert A
Eur Neurol; 2008; 60(2):67-72. PubMed ID: 18480610
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis.
Kvetny J; Puhakka KB; Røhl L
Acta Ophthalmol Scand; 2006 Jun; 84(3):419-23. PubMed ID: 16704711
[TBL] [Abstract][Full Text] [Related]
3. Graves' ophthalmopathy: eye muscle involvement in patients with diplopia.
Nagy EV; Toth J; Kaldi I; Damjanovich J; Mezosi E; Lenkey A; Toth L; Szabo J; Karanyi Z; Leovey A
Eur J Endocrinol; 2000 Jun; 142(6):591-7. PubMed ID: 10832104
[TBL] [Abstract][Full Text] [Related]
4. Clinical challenge: An orbital Hickam's dictum.
Wilson ME; Thornton S; Murchison AP; Bilyk JR
Surv Ophthalmol; 2016; 61(6):799-805. PubMed ID: 26994869
[TBL] [Abstract][Full Text] [Related]
5. Exophthalmos in a young woman with no graves' disease - a case report of IgG4-related orbitopathy.
Erdei A; Steiber Z; Molnar C; Berenyi E; Nagy EV
BMC Ophthalmol; 2018 Jan; 18(1):5. PubMed ID: 29329570
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves' orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation.
Moshkelgosha S; So PW; Deasy N; Diaz-Cano S; Banga JP
Endocrinology; 2013 Sep; 154(9):3008-15. PubMed ID: 23900776
[TBL] [Abstract][Full Text] [Related]
7. Can autoimmunity against calsequestrin explain the eye and eyelid muscle inflammation of thyroid eye disease?
Gopinath B; Wescombe L; Nguyen B; Wall JR
Orbit; 2009; 28(4):256-61. PubMed ID: 19839885
[TBL] [Abstract][Full Text] [Related]
8. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease.
Goh SY; Ho SC; Seah LL; Fong KS; Khoo DH
Clin Endocrinol (Oxf); 2004 May; 60(5):600-7. PubMed ID: 15104563
[TBL] [Abstract][Full Text] [Related]
9. [Endocrine orbitopathy and significance of autoantibodies against 1D protein].
Hrdá P; Sterzl I; Vána S; Novák Z; Matucha P; Kromminga A
Cas Lek Cesk; 2007; 146(3):273-7. PubMed ID: 17419313
[TBL] [Abstract][Full Text] [Related]
10. Studies of retroorbital tissue xenografts from patients with Graves' ophthalmopathy in severe combined immunodeficient (SCID) mice: detection of thyroid-stimulating antibody.
Mori S; Yoshikawa N; Tokoro T; Ikehara S; Inoue Y; Nishikawa M; Inada M
Thyroid; 1996 Aug; 6(4):275-81. PubMed ID: 8875746
[TBL] [Abstract][Full Text] [Related]
11. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic orbital hemorrhage related to the inferior rectus muscle: a rare cause for acute-onset diplopia and unilateral proptosis.
Ben Simon GJ; McNab AA
Ophthalmology; 2005 Oct; 112(10):1838-43. PubMed ID: 16095703
[TBL] [Abstract][Full Text] [Related]
13. Severe Graves' Orbitopathy occurring in a patient with thyroid hemiagenesis.
Meringolo D; Campi I; Costante G
Endocrine; 2018 Nov; 62(2):490-491. PubMed ID: 29987702
[No Abstract] [Full Text] [Related]
14. Primary orbital liposarcoma misdiagnosed as thyroid associated orbitopathy.
Shinder R; Mostafavi D; Nasser QJ; Esmaeli B; Shore JW
Orbit; 2012 Aug; 31(4):264-6. PubMed ID: 22571512
[TBL] [Abstract][Full Text] [Related]
15. [Endocrine orbitopathy - the topic still alive].
Fryšák Z; Karásek D; Halenka M
Vnitr Lek; 2016; 62(9 Suppl 3):56-62. PubMed ID: 27734693
[TBL] [Abstract][Full Text] [Related]
16. Dry Eye Syndrome in Non-Exophthalmic Graves' Disease.
Bruscolini A; Abbouda A; Locuratolo N; Restivo L; Trimboli P; Romanelli F
Semin Ophthalmol; 2015; 30(5-6):372-6. PubMed ID: 24460515
[TBL] [Abstract][Full Text] [Related]
17. Rapid response to and long-term effectiveness of anti-CD20 antibody in conventional therapy resistant Graves' orbitopathy: A five-year follow-up study.
Erdei A; Paragh G; Kovacs P; Karanyi Z; Berenyi E; Galuska L; Lenkey A; Szabados L; Gyory F; Ujhelyi B; Berta A; Boda J; Berta E; Bodor M; Gazdag A; Nagy EV
Autoimmunity; 2014 Dec; 47(8):548-55. PubMed ID: 25039242
[TBL] [Abstract][Full Text] [Related]
18. Relationship of eye muscle antibodies with HLA phenotypes and thyroid-stimulating immunoglobulins in endocrine orbitopathy.
Kahaly G; Moncayo R; Stover C; Beyer J
Res Exp Med (Berl); 1991; 191(2):137-44. PubMed ID: 1677484
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of TSH receptor antibodies measurement in patients with Graves' orbitopathy.
Eckstein A; Esser J; Mann K; Schott M
Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():198-203. PubMed ID: 20467363
[TBL] [Abstract][Full Text] [Related]
20. The relationship between anti-human eye muscle antibodies and thyroid function, anti-TSH receptor antibodies and eye symptoms in Graves' ophthalmopathy.
Molnár I; Balázs C
Wien Klin Wochenschr; 1992; 104(24):744-7. PubMed ID: 1363165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
